Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
View/Download PDF

Translate this page into:

Editorial
14 (
01
); 001-003
doi:
10.1055/s-0043-1767699

Technology and Innovation Has Made Impact Factor Redundant—Better Alternatives Are Here to Thrive

Department of Clinical Hematology, Mahatma Gandhi University of Medical Sciences and Technology, Jaipur, Rajasthan, India
Department of Medical Oncology, Hope Oncology Clinic, New Delhi, India

*Corresponding author: Purvish M. Parikh, MD, DNB, FICP, PhD, ECMO, CPI, Jaipur, 302022, Rajasthan, India. purvish1@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
Purvish M. Parikh
FI22121111-1 Purvish M. Parikh

Three recent publications have let the cat out of the bag. They are “Stop Congratulating Colleagues for Publishing in High Impact-Factor Journals,” “Who are the real parasite publishers and journals? What prevents all medical data from being open access in real time?” and “Against Parasite Publishers: Making Journals Free.”123

For long impact factor (IF) has ruled the academic publishing world. It has expanded its sphere of influence on career progress, appointments in academic institutions, promotion reviews, and grant applications. IF is popular since 1975 and is based on the number of citations that the journal received in the previous 2 years. For instance, if our article is published in the year 2022, the IF that the journal in which our article is published will be decided on the citations received by the journal in the years 2020 and 2021. Authors are cognizant of the significance of IF because journals with higher IF are considered as respectable, their review process is supposed to be selective, there is greater scrutiny of articles submitted, and if published, the authors are considered worthy by their peers. Publications in journals with high IF also cascade into wider publicity through reporting by science journals and social media. They also have a higher chance of being included in reports on new publications. As the definition suggests, there is also a higher chance of being cited by other scientists working in the field.

However, IF has a very important flaw. All the metrics are related to the journal. There is no evaluation of the individual publication or the author who has done the research work. Therefore, having a publication in a high IF journal does not guarantee that your work will be cited. In fact, more than two-thirds of publications in such journals have fewer citations than the IF of the journal.4

By experience, we have found that using the right keywords does wonders to online access. When the research work is great, those interested in the subject can easily find it on the net. Searchable databases such as Scopus, Google Scholar, and Web of Science make this possible.

There are also niche areas in science and medicine, where journals with high IF simply do not exist. The research communities in such fields are small and usually know each other well. So, they tend to find work of colleagues online even if published in journals with IF of 3 or 4.

As journals with high IF are in “great demand,” their review process is time consuming and ultimately most of the work submitted does not get accepted. In the process, our data may become redundant in today's exponentially progressive research environment. Can we afford to face this?

The final stumbling block is that if such journals are open access, they command a high premium in terms of publication “processing fees.” For instance, last year, Nature announced a princely sum of Euro 9,500 as their charges if the authors wanted their article to have open access. Clearly, this is an elitist attitude where rich publishing houses want to get richer at the cost of dissemination of information. This has a major health care implication. Work from low- and medium-income countries (LMIC) will not be published in such journals. Or the work will be behind a paywall that the LMIC colleagues cannot surmount.5

No wonder global citation inequality is increasing. Data between 2000 and 2015 encompassing 1 million authors and 26 million scientific publications show interesting confirmation of the same.6 Citations have increased from 14 to 21% only for the tip 1% of most cited researchers. The increasing trend was most prominent in the Netherland, Denmark, Australia, and United Kingdom. Interestingly, it showed a decline in the United States and China.

IF has actually become so frustrating and misleading that many grant providers have started ignoring any reference to it. The European Research Council has taken a step further by banning mention of journal IF from all grant proposals and bids submitted to them.7

So, the question that begs an answer is, what are the alternative metrics that we can use and which of them is the most likely to replace IF?

SCImago Journal and Country Rank, Eigenfactor Metrics, and Science Gateway need mention only to say that they exist but pale in comparison to IF.

In 2005, Hirsch published another metric to evaluate the scientific research output of individual scientists and researchers.8 This was labeled as the H index factor. It is based on two data points. One is the number of journal articles the author has published. The other is the number of citations received by those articles (of the same author). An example from publications from one of us shows that number of total citations as 12,103 and the H index as 34, as calculated using Google Scholar.9 Let us take another example. Charles Darwin died in the year 1882, but his legacy is still very much alive. His publications have received at least 77,539 citations giving him an H index of 80. There are several videos available on YouTube that can provide greater details about the H index factor.10

Google is extremely innovative. And Google Scholar came up with a great and simple metric. Their i10-index simply looks at the number of publications of the author that has at least 10 citations.11 This is free and easy to use. It also specifically gauges the productivity of individual researchers. The only flaw is that no differential weightage is given based on the sequence of authorship.

Web of Science citation tool uses searches from many databases and citation indexes. They allow free membership and can display the citations and H index in graphic form. Advantage is that it separates out the self-citation. Another useful tool is what they call Beamplot Summary, which shows the author citations through time—recent versus older versus earliest. This showcases impact of junior scientists using a graphic visualization tool.12

PLos article-level metrics is different because it allows evaluation of articles before they accrue citations, adds social metrics, and also shows how the influence of the published work changes over time. These advantages would make it invaluable, but for the fact that most access is behind a paywall called “premium products.”13

“Publish or Perish” is the name of an app that searches and retrieves academic citations and analyzes them.14 They want us to believe that it is the equivalent of the holy grail, allowing scientists to decide which journals to select for publication, preparing for a job interviews, conducting literature review, do homework before promotion interviews, etc. Unfortunately, it does not live up to the hype.

Author disambiguation has become really critical because social media has exploded with easy access and tons of data being added every second. When authors share names, it becomes imperative to separate the work of one from that of the other. Sophisticated tools have been developed to do this automatically based on affiliation, e-mail, designation, area of interest, etc.15 Unfortunately, it needs improvement. Thankfully scientists can contribute themselves to being attributed corrected. For instance, ORCID and Web of Science ID help researchers identify their work and not be confused for someone else.16

Indian Citation Index is the name of an India portal that has also jumped into the foray.17 Online bibliographic database from academic journals. When we checked last, it covered 1,100+ journals from India from 2004 onward. It includes full-text articles from open access journals too. It was launched in India in 2009 by Diva Enterprises Pvt. Ltd. Being a private enterprise, access is not free. When we tried to sign up, we were given the generous time of 2 hours of complementary access!

In summary, the citation metrics and indices can be divided into three broad categories: those which are general purpose subscription based, those that are general purpose free online, and those which are subject specific.

Publication is vital and a high stake factor for academics.18 This is like a shadow that follows us right from the first conference abstract acceptance to the final philosophical pearls of wisdom that seniors share with their juniors and colleagues. Since the early 1980s, this has gained increasing importance and now dictates navigating the academic pathway. Technology evolution and importance of social media have changed the landscape. We now seem to have a say in how our work gets disseminated. We also have the opportunity to control the pace and width that our work reaches, at least to some extent.19 This helps us in the path toward optimizing online reputation and no longer be at the mercy of complex evaluation metric systems controlled by a select few. In fact, conferences are now rewarding those delegates that instantly post live comments about research—as it is being presented. Welcome to the new academic digital world.

References

  1. , , , et al . Accessed on December 1, 2022 at:
  2. Accessed on December 1, 2022 at:
  3. , , . Who are the real parasite publishers and journals? What prevents all medical data from being open access in real-time? Indian J Med Sci. 2022;74:109-111.
    [Google Scholar]
  4. , . Beat it, impact factor! Publishing elite turns against controversial metric. Nature. 2016;535:210-211.
    [Google Scholar]
  5. Accessed on December 1, 2022 at:
  6. , , . Global citation inequality is on the rise. Proc Natl Acad Sci U S A. 2021;118(07):e2012208118.
    [Google Scholar]
  7. Accessed on December 1, 2022 at:
  8. , . An index to quantify an individual's scientific research output. Proc Natl Acad Sci U S A. 2005;102(46):16569-16572.
    [Google Scholar]
  9. Accessed on December 1, 2022 at:
  10. Accessed on December 1, 2022 at:
  11. Accessed on December 1, 2022 at:
  12. Accessed on December 1, 2022 at:
  13. Accessed on December 1, 2022 at:
  14. Accessed on December 1, 2022 at:
  15. , , . Researcher, author and reviewer profiles. J R Coll Physicians Edinb. 2022;52(04):282-284.
    [Google Scholar]
  16. Accessed on December 1, 2022 at:
  17. Accessed on December 1, 2022 at:
  18. , , , et al . Statement on publishing clinical trials in Indian biomedical journals. Indian J Med Sci. 2008;62(04):132-133.
    [Google Scholar]
  19. , . The case report controversy. Accesses on December 2, 2022 at:
    [Google Scholar]

    Fulltext Views
    16

    PDF downloads
    4
    View/Download PDF
    Download Citations
    BibTeX
    RIS
    Show Sections